Age-Associated Cross-reactive Antibody-Dependent Cellular Cytotoxicity Toward 2009 Pandemic Influenza A Virus Subtype H1N1-Reference-Cited by-同舟云学术

Age-Associated Cross-reactive Antibody-Dependent Cellular Cytotoxicity Toward 2009 Pandemic Influenza A Virus Subtype H1N1

Published:2013-06-28 Issue:7 Volume:208 Page:1051-1061
ISSN:1537-6613
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Jegaskanda Sinthujan,Laurie Karen L.,Amarasena Thakshila H.,Winnall Wendy R.,Kramski Marit,De Rose Robert,Barr Ian G.,Brooks Andrew G.,Reading Patrick C.,Kent Stephen J.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/208/7/1051/18069867/jit294.pdf

Reference39 articles.

1. Emergence of a novel swine-origin influenza A (H1N1) virus in humans;Dawood;N Engl J Med,2009

2. Severe respiratory disease concurrent with the circulation of H1N1 influenza;Chowell;N Engl J Med,2009

3. Critical care services and 2009 H1N1 influenza in Australia and New Zealand;Webb;N Engl J Med,2009

4. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009;Jain;N Engl J Med,2009

5. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China;Cao;N Engl J Med,2009

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza antibody breadth and effector functions are immune correlates from acquisition of pandemic infection of children;Nature Communications;2024-04-13

2. Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses;Journal of Virology;2023-11-30

3. Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza;JCI Insight;2023-07-24

4. Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations;Frontiers in Immunology;2023-06-27

5. Inactivated and Recombinant Influenza Vaccines;Plotkin's Vaccines;2023